患有急性髓性白血病的老年患者的发展趋势和结果,包括全源干细胞移植
Alexandre Bazinet1, Hagop Kantarjian1, Naszrin Arani2
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
患有急性髓性白血病 (AML) 的老年人的结局正在通过低强度治疗 (LIT) 得到改善,特别是与venetoclax结合使用时. 干细胞移植 (SCT) 进一步提高了符合条件的患者的生存率.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
背景情况:
- 老年人 (≥60岁) 患有急性髓性白血病 (AML) 历史上面临着糟糕的结果.
- 低强度疗法 (LIT) 和干细胞移植 (SCT) 的进展需要评估当代治疗对这一群体的疗效.
结论:
- 当代LIT,特别是venetoclax,改善了老年AML患者的缓解率和存活率.
- 干细胞移植提供了显著的生存益处,应该在符合条件的老年人中更积极地进行.
- 增加获得SCT的机会对于改善急性髓性白血病的老年患者的治疗结果至关重要.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
相关概念视频
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Differentiation of Common Myeloid Progenitor Cells
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
